Roche Holding AG (ROP.SW) — Technical state
As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 56 out of 100 (momentum 79 · quality 84 · valuation 51), as of 2026-11-06.
- Signal: Uptrend stack intact — Trades +6.6% vs the 50-day and +14.2% vs the 200-day average, 3.5% below the 52-week high and +56% off the 52-week low. Computed from daily closes. (as of 2026-11-05)
- Trend: Roche Holding AG trades 6.6% above its 50-day and 14.2% above its 200-day moving average. (as of 2026-11-05)
Roche Holding AG is a Swiss healthcare group split between pharmaceuticals and diagnostics, headquartered in Basel. Its medicines cover areas such as oncology, immunology, neurology, ophthalmology and infectious disease, while its diagnostics arm supplies tests and instruments used to detect conditions including cancer, diabetes and hepatitis.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ROP.SW overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +6.6% vs the 50-day and +14.2% vs the 200-day average, 3.5% below the 52-week high and +56% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+1.4%
- vs 50-day+6.6%
- vs 200-day+14.2%
- 52-week band3.5% off the high · +56% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 18 sessions ago
- Stochastic%K 51.4 · %D 69.3
Continue: the ROP.SW chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-05
Quick answers
What is the current Closelooknet signal on ROP.SW?
Uptrend stack intact — Trades +6.6% vs the 50-day and +14.2% vs the 200-day average, 3.5% below the 52-week high and +56% off the 52-week low. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ROP.SW above its 50-day and 200-day moving averages?
As of 2026-11-05, Roche Holding AG trades +6.6% above its 50-day and +14.2% above its 200-day average, with the 20-day +1.4% away.
How far is ROP.SW from its 52-week high?
3.5% below the 52-week high and 56% above the 52-week low, as of 2026-11-05.
Related in the Closelooknet universe
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector
- ANN.AU Ansell Ltdsector
- ARGX.BR Argen-Xsector
- UCB.BR UCB SAsector
- ARGX argenx NV ADRsector
- DXCM DexCom Incsector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- RIGL Rigel Pharmaceuticals Incsector
- HQY HealthEquity Incsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- REGN Regeneron Pharmaceuticals Incsector
- CEVI.ST CellaVision ABsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector
- BION.SW BB Biotech AGsector
- PTGX Protagonist Therapeutics Incsector
- SAN.PA Sanofi SAsector
- SECT-B.ST Sectra AB (publ)sector